Fair enough Captain . Yet I still cannot for the life of me see a 20/1 variation in value per person. With 10 times the price paid and only half population this is the price. US medication prices have had the lights belted out of them since Trump elected 2016. The Pharmaceuticals have all been rocked since. The average American Woman is far more savvy now regarding pricing. They are well aware they had been ripped off in the past even for Generics. This was Mayne problem in Teva Deal. Due Diligence would have informed Blind Freddy we were paying an extremely inflated price for the so called 42 products. Non of them worth ZIP 5 years later and we are $900m poorer. Broke basically. Then Nuvaring ( The carrot) still not approved in US ( A Generic ). Seriously !! So Mithra deal again with E4 To achieve a revenue of $200m cost including shareholding $529m. Honestly, what next ??? I really do believe there may need to be an inquiry into Fornieri and Richards contract negotiations and agreement. Mr Francois Fornieri although not yet found guilty of insider trading has been charged with it and had to step down as CEO of Mithra. I mean this is the company upon which Mayne entire existence is dependent. They 100% own and will manufacture and supply us to purely market two products. We don’t even have manufacturing rights. One thing goes wrong with Mithra or who knows what May come up regarding FF.
MYX Price at posting:
38.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)